HOME >> MEDICINE >> NEWS
Walking Or Bed Rest OK For First Stage Of Labor, UT Southwestern Research Shows

DALLAS -- July 9, 1998 -- In the largest study of its kind, UT Southwestern Medical Center at Dallas obstetrics and gynecology researchers have concluded that walking during the first stage of labor is neither harmful nor beneficial to the mother or baby.

Dr. Steven Bloom, assistant professor of obstetrics and gynecology and lead author of the study published in today's New England Journal of Medicine, said women should be allowed to either walk or remain in bed during the first stage of labor, whichever is most comfortable to them. Current obstetrics practice dictates that a woman lie down during labor, but, as many doctors know, patients sometimes want to walk around, hoping to find comfort in motion.

Bloom and his colleagues assigned 1,067 women at Parkland Memorial Hospital in Dallas in spontaneous labor with uncomplicated pregnancies between 36 and 41 weeks' gestation to either a walking group or a bed-rest group. Seventy-eight percent of those assigned to the walking group actually walked; the rest had quicker labors, which may have precluded them from walking. Those in the bed-rest group were allowed to sit up. The researchers compared such factors as duration of the first stage of labor, the need for labor augmentation with medication, the use of analgesia for pain and the percentages of forceps deliveries and Caesarean sections.

"Labor and delivery outcomes were unrelated to walking, and infants' outcomes were also similar in the two study groups," Bloom concluded. "Walking neither enhanced nor impaired active labor and was not harmful to the mothers or their infants. Most of those who did walk indicated that they would do so again in a future labor. Since our results provide no objective evidence for or against walking during labor, it seems reasonable to let women elect either alternative."

This study brings the debate of walking or bed rest full circle since the first of the century. Bloom explained
'"/>

Contact: Ann Harrell
ann.harrell@email.swmed.edu
(214) 648-3404
UT Southwestern Medical Center
9-Jul-1998


Page: 1 2

Related medicine news :

1. Walking markedly improves mental abilities of those over 60
2. Walking cuts risk of heart attack in elderly men
3. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
4. First UK cases of previously rare disease reported in gay men
5. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
6. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
7. First US kidney cancer vaccine trial underway at Columbia
8. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
9. First blood test to diagnose paralyzing, blinding disease
10. First US SARS vaccine trial opens at NIH
11. First-ever safety study of medical cannabis use in Canada launched

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Walking Bed Rest For First Stage Labor Southwestern Research Shows

(Date:7/30/2015)... ... July 30, 2015 , ... Zejax is ... Tool That Increases Training Capability , World renown body weight trainer, Paul ... http://www.Zejax.com ), that dramatically increases a person’s training capability. , The American College ...
(Date:7/30/2015)... Angeles, California (PRWEB) , ... July 30, 2015 , ... ... the success of the 2015 Special Olympics World Games, the largest sports and humanitarian ... since the 1984 Olympic Games. , The World Games, held July 25 through August ...
(Date:7/30/2015)... Wisconsin (PRWEB) , ... July 30, 2015 , ... Quintessa ... Kybella is a nonsurgical treatment designed specifically for the elimination of ... one of the first locations in the state of Wisconsin to offer this innovative ...
(Date:7/30/2015)... ... July 30, 2015 , ... The New Jersey Innovation ... Jersey Department of Health, has received a $2.9 million grant from the Office ... Department of Health and Human Services (HHS). NJII will help the Department of ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Bird B ... a new bird hazing system to repel pest birds from the AC ... diseases—including histoplasmosis, encephalitis, salmonella, meningitis, and toxoplasmosis, even the West Nile virus. When these ...
Breaking Medicine News(10 mins):Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:WesternU Makes Big Impact at Special Olympics 2Health News:WesternU Makes Big Impact at Special Olympics 3Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2
(Date:7/30/2015)... NEW YORK , July 30, 2015 ... releases a new research report with market ... size, share, forecast, porter analysis, recent developments, ... Global Industry Insight: Biosensors Market ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) ...
(Date:7/30/2015)... , July 30, 2015 Takeda ... the study to fulfill the post-marketing commitment and ... Pan European Multi-Database Bladder Cancer Risk Characterization ... matched cohort study, conducted in four European countries, ... with up to 10 years of follow-up. Findings ...
(Date:7/30/2015)... July 30, 2015 Vermillion, Inc. ... gynecologic disease, announced today it will report ... the market close on Thursday, August 13, ... and webcast at 4:30pm Eastern.Conference Call and ... 4:30pm Eastern/1:30pm Pacific  Domestic: , ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
Cached News: